Story thread · 2 reports / 2 sources
Guggenheim upgrades Editas Medicine stock rating on gene editing therapy
investing.com · 16h · first report
The coverage
- Editas raised to Buy at Guggenheim on cholesterol therapy
seekingalpha.com · 12h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.